Memantine hydrochloride 2 MG/ML Oral Solution — RxCUI 996740
RxNorm drug concept · Semantic clinical drug
RxCUI 996740
Semantic clinical drug · SCD
● Current RxNorm concept 5 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI996740
Official nameMemantine hydrochloride 2 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmemantine HCl 2 MG per 1 ML Oral Solution; memantine HCl 2 MG in 1 mL Oral Solution; memantine HCl 10 MG per 5 ML Oral Solution
FDA products mapped5
Package NDCs mapped6
Reported Medicaid activity (SDUD)453 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Memantine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Memantine helps manage the symptoms of moderate to severe Alzheimer's disease. It works by blocking certain brain receptors that are overstimulated in Alzheimer's, which is thought...
- What does memantine actually do for Alzheimer's disease?
- No — memantine can be taken with or without food, whichever is easier to stick with. For the extended-release capsule form, food does slightly affect the timing of when the drug pe...
- Just skip the missed dose and take your next dose at the regularly scheduled time. Never double up to make up for a missed one. If you've missed several days in a row, don't just r...
🕸️ Concept Web — How Memantine hydrochloride 2 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Memantine hydrochloride 2 MG/ML Oral Solution
RxCUI 996740 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Memantine
6719IN -
Memantine hydrochloride
236685PIN
-
Memantine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Memantine Oral Solution
577156SCDF -
Memantine hydrochloride Oral Solution
2646062SCDFP -
Memantine Oral Liquid Product
1159791SCDG -
Memantine Oral Product
1159792SCDG -
Memantine hydrochloride Oral Liquid Product
2661025SCDGP -
Memantine hydrochloride Oral Product
2660255SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Memantine Oral Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Memantine hydrochloride 2 MG/ML
996739SCDC
-
Memantine hydrochloride 2 MG/ML
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Memantine hydrochloride 2 MG/ML
SCDC · 996739 -
Memantine Oral Solution
SCDF · 577156 -
Memantine hydrochloride Oral Solution
SCDFP · 2646062 -
Memantine Oral Liquid Product
SCDG · 1159791 -
Memantine Oral Product
SCDG · 1159792 -
Memantine hydrochloride Oral Liquid Product
SCDGP · 2661025 -
Memantine hydrochloride Oral Product
SCDGP · 2660255
📦 FDA Products & Package NDCs
5 products · 6 package NDCs
6 package NDCs map to RxCUI 996740 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 13925-0540-12 | 360 mL in 1 BOTTLE (13925-540-12) | Memantine Hydrochloride | Seton Pharmaceuticals | 2021-05-19 |
| 33342-0066-28 | 240 mL in 1 BOTTLE (33342-066-28) | Memantine Hydrochloride | Macleods Pharmaceuticals Limited | 2015-10-13 |
| 60505-6162-05 | 1 BOTTLE in 1 CARTON (60505-6162-5) / 360 mL in 1 BOTTLE | MEMANTINE | Apotex Corp. | 2018-04-30 |
| 62135-0943-24 | 2 TRAY in 1 BOX (62135-943-24) / 10 CUP in 1 TRAY / 5 mL in... | Memantine Hydrochloride | Chartwell RX, LLC | 2025-02-25 |
| 62135-0943-37 | 240 mL in 1 BOTTLE (62135-943-37) | Memantine Hydrochloride | Chartwell RX, LLC | 2022-10-27 |
| 68999-0943-24 | 2 TRAY in 1 BOX (68999-943-24) / 10 CUP in 1 TRAY / 5 mL in... | Memantine Hydrochloride | Chartwell Governmental & Specialty RX, LLC. | 2026-02-02 |
Observed labelers:
Chartwell RX, LLC (2) ·
Apotex Corp. (1) ·
Chartwell Governmental & Specialty RX, LLC. (1) ·
Macleods Pharmaceuticals Limited (1) ·
Seton Pharmaceuticals (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.5976
Range $0.3908–$0.8043
· middle 50% $0.3908–$0.8043
· 4 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.